Search clinical trials for: ES101

Total 24 results

Elpiscience Biopharma, Ltd.

Withdrawn

A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors

Small Cell Lung Cancer | Non-small Cell Lung Cancer | Thoracic Tumors
Elpiscience Biopharma, Ltd.

Terminated

A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Solid Tumors

Neoplasms | Solid Tumors | Malignant Tumor

China
Equillium
Equillium AUS Pty Ltd

Active, not recruiting

Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata

Alopecia | Alopecia Areata | Alopecia Totalis | Alopecia Universalis

Australia, New Zealand
Elpiscience Biopharma, Ltd.

Active, not recruiting

A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors

Neoplasms | Solid Tumors | Malignant Tumor

China
EXACT Therapeutics AS

Recruiting

PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin (ACT)

Colorectal Cancer | Solid Tumor

United Kingdom, Norway
Elpiscience (Suzhou) Biopharma, Ltd.

Active, not recruiting

A Study of ES104 in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Chordate Medical

Completed

Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis (KOSNAR)

Nasal Congestion | Non-allergic Rhinitis

Finland, Italy, United Kingdom, Greece, Netherlands, Czechia
Mundipharma Research Limited

Completed

Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors

Soft Tissue Sarcoma | Ovarian Cancer | Endometrial Cancer | Small-cell Lung Cancer | Triple-negative Breast Cancer

United States, Canada
Eutilex

Recruiting

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Renal Cell Carcinoma | Non-Small Cell Lung Cancer | Solid Tumor | Prostate Cancer | Renal Cell Cancer Metastatic

United States, Korea, Republic of
Neuracle Science Co., LTD.
Samsung Medical Center; Korea University Anam Hospital; Severance Hospital

Recruiting

A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients

Sudden Sensorineural Hearing Loss | Seneorineural Deafness

Korea, Republic of
Elpiscience Biopharma, Ltd.
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors

Neoplasms | Solid Tumor | Malignant Tumor

China
Neuracle Science Co., LTD.

Completed

A FIH Study to Assess the Safety and Tolerability of NS Intravenous NS101 Infusion

Neurodegenerative Diseases

Canada
ViSci Ltd.

Completed

A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

United States
Aesculap AG

Completed

Orthopilot Elite Post-Market Clinical Follow-Up

Rheumatoid Arthritis | Instability, Joint | Degenerative Osteoarthritis | Posttraumatic Arthropathy | Deformity of Knee | Stiffness of Knee, Not Elsewhere Classified

Germany
IgNova GmbH
Klinar CRO; Scope International AG; CenTrial GmbH; Pharmasolutions4U; idv Data Analysis...

Completed

Efficacy and Safety of IGN-ES001 in Chronic Widespread Pain With or Without Fibromyalgia

Chronic Widespread Pain | Fibromyalgia

Turkey
BioMAS Ltd

Terminated

Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients

Chemotherapy Induced Thrombocytopenia

Israel
BioMAS Ltd

Unknown

Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts

External Genital Warts

Israel
BioMAS Ltd

Withdrawn

Topical Application of AS101 for the Treatment of Psoriasis

Mild to Moderate Psoriasis

Israel
BioMAS Ltd

Terminated

Topical Application of AS101 for the Treatment of Atopic Dermatitis

Atopic Dermatitis

Israel
BioMAS Ltd

Completed

Safety and Efficacy Study to Test Topical AS101 for External Genital Warts

Condyloma Acuminata | Wart; External Genital Organs

Israel
Rabin Medical Center

Unknown

Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women

Alopecia

Israel
BioMAS Ltd

Suspended

Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Israel
Feramda

Completed

Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Neovascular Age-related Macular Degeneration

Israel
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma

Glioblastoma | Gliosarcoma | MGMT-Unmethylated Glioblastoma

United States

Search clinical trials for: ES101

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations